precision oncology | pharmaphorum

precision oncology

News

Recursion BioHive

Bayer pledges up to $1.5bn for Recursion oncology alliance

Bayer has restructured and expanded its ongoing partnership with Recursion Pharmaceuticals on artificial intelligence-powered drug discovery, switching to a focus on cance

Oncology

cancer treatment

Elements in precision oncology

Validating the regulatory expectations on evidential requirements for predictive biomarkers is not a trivial process, but quite conceptually challenging.

Oncology

Breast cancer genomics oncology

Oncotype DX: Breast cancer, genomics, and rethinking the onc...

EXACT Sciences presented ten new pieces of data at the San Antonio Breast Cancer Symposium (SABCS) back in late 2022, highlighting the impact of its precision oncology portfolio on breast c

Digital

staffing burnout rates

Tackling ongoing staffing burnout rates through AI-enabled p...

The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows.

News

Nucleai_logo

Sanofi backs precision oncology firm Nucleai in $33m fundrai...

Israeli startup Nucleai has raised $33 million in a second-round financing that will be used to further its work on using artificial inte

Events

Gastrointestinal Cancer Drug Development Summit Register Free

Partner Content

FREE - Gastrointestinal Cancer Drug Development Digital Summ...

FREE - Gastrointestinal Cancer Drug Development Summit